56.68000 USD
1.41
2.43%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
55.52000
58.5
Previous close
58.090000
Open
57.95000
Access this stock data via API
Subscribe
Crispr Therapeutics AG
56.68
1.41
2.43%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 35M 370M 436K 913.1M
Cost of revenue 110.3M 130.3M 110.3M 101.2M
Gross profit -75.3M 239.8M -109.8M 811.9M
Operating expense
Research & development 320.7M 387.3M 461.6M 340.6M
Selling general and admin 73.0M 76.2M 102.5M 99.7M
Other operating expenses -2.3M -1.2M -762K -1.9M
Operating income -466.6M -222.5M -673.2M 373.5M
Non operating interest income
Income
Expense
Other income expense 103.9M 71.8M 22.7M 6.0M
Pretax income -362.7M -150.7M -650.5M 379.5M
Tax provision 3.6M 2.9M -325K 1.9M
Net income -366.3M -153.6M -650.2M 377.7M
Basic EPS -4.3 -1.9 -8.4 5.0
Diluted EPS -4.3 -1.9 -8.4 4.7
Basic average shares 84.4M 79.2M 77.7M 75.9M
Diluted average shares 84.4M 79.2M 77.7M 75.9M
EBITDA -447.3M -202.7M -649.0M 391.5M
Net income from continuing op. -366.3M -153.6M -650.2M 377.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 10 hours 46 minutes

17:13
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).